DTIL
Precision Biosciences Inc
$8.24
+0.06 (+0.73%)
At close · Jul 6
Market Cap
$212.61M
Shares
25,802,247
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-03 | Germano Geno J |
Director | Award | 20,979 |
| 2026-06-03 | Pire Shari Lisa |
Director | Award | 20,979 |
| 2026-06-03 | Frankel Stanley |
Director | Award | 20,979 |
| 2026-06-03 | Buehler Kevin |
Director | Award | 20,979 |
| 2026-06-03 | Brown Melinda |
Director | Award | 20,979 |
| 2026-06-01 | SMITH J. JEFFERSON |
Chief Research Officer | Award | 57,389 |
| 2026-06-01 | Amoroso Michael |
Director | Award | 573,888 |
| 2026-06-01 | Kelly John Alexander |
Chief Financial Officer | Award | 193,688 |
| 2026-06-01 | Scimeca Dario |
General Counsel and Secretary | Award | 107,604 |
| 2026-05-20 | Pire Shari Lisa |
Director | Convert | 21,000 |
| 2026-05-20 | Brown Melinda |
Director | Convert | 21,000 |
| 2026-05-20 | Frankel Stanley |
Director | Convert | 21,000 |
| 2026-05-20 | Germano Geno J |
Director | Convert | 21,000 |
| 2026-05-20 | Brown Melinda |
Director | Convert | 21,000 |
| 2026-05-20 | Buehler Kevin |
Director | Convert | 21,000 |
| 2026-05-20 | Germano Geno J |
Director | Convert | 21,000 |
| 2026-05-20 | Buehler Kevin |
Director | Convert | 21,000 |
| 2026-05-20 | Pire Shari Lisa |
Director | Convert | 21,000 |
| 2026-05-20 | Frankel Stanley |
Director | Convert | 21,000 |
| 2026-02-18 | SMITH J. JEFFERSON |
Chief Research Officer | Sell | 4,925 |
| 2026-02-18 | Scimeca Dario |
General Counsel and Secretary | Sell | 4,925 |
| 2026-02-18 | Amoroso Michael |
Director | Sell | 20,559 |
| 2026-02-18 | Kelly John Alexander |
Chief Financial Officer | Sell | 8,149 |
| 2026-02-17 | Scimeca Dario |
General Counsel and Secretary | Convert | 16,667 |
| 2026-02-17 | SMITH J. JEFFERSON |
Chief Research Officer | Convert | 16,667 |
| 2026-02-17 | Scimeca Dario |
General Counsel and Secretary | Convert | 16,667 |
| 2026-02-17 | Kelly John Alexander |
Chief Financial Officer | Convert | 27,584 |
| 2026-02-17 | Kelly John Alexander |
Chief Financial Officer | Convert | 27,584 |
| 2026-02-17 | SMITH J. JEFFERSON |
Chief Research Officer | Convert | 16,667 |
| 2026-02-17 | Amoroso Michael |
Director | Convert | 67,797 |
| 2026-02-17 | Amoroso Michael |
Director | Convert | 67,797 |
| 2026-01-22 | Amoroso Michael |
Director | Sell | 34,799 |
| 2026-01-21 | SMITH J. JEFFERSON |
Chief Research Officer | Sell | 10,200 |
| 2026-01-21 | Kelly John Alexander |
Chief Financial Officer | Sell | 15,213 |
| 2026-01-21 | SMITH J. JEFFERSON |
Chief Research Officer | Convert | 16,219 |
| 2026-01-21 | Scimeca Dario |
General Counsel and Secretary | Sell | 8,854 |
| 2026-01-20 | Amoroso Michael |
Director | Convert | 8,888 |
| 2026-01-20 | SMITH J. JEFFERSON |
Chief Research Officer | Convert | 2,500 |
| 2026-01-20 | SMITH J. JEFFERSON |
Chief Research Officer | Convert | 2,500 |
| 2026-01-20 | Kelly John Alexander |
Chief Financial Officer | Convert | 13,900 |
| 2026-01-20 | Scimeca Dario |
General Counsel and Secretary | Convert | 8,425 |
| 2026-01-20 | Amoroso Michael |
Director | Convert | 69,421 |
| 2026-01-20 | Amoroso Michael |
Director | Convert | 37,069 |
| 2026-01-20 | Kelly John Alexander |
Chief Financial Officer | Convert | 13,900 |
| 2026-01-20 | Kelly John Alexander |
Chief Financial Officer | Convert | 3,888 |
| 2026-01-20 | Amoroso Michael |
Director | Convert | 37,069 |
| 2026-01-20 | Scimeca Dario |
General Counsel and Secretary | Convert | 1,978 |
| 2026-01-20 | Scimeca Dario |
General Counsel and Secretary | Convert | 14,908 |
| 2026-01-20 | Scimeca Dario |
General Counsel and Secretary | Convert | 8,425 |
| 2026-01-20 | Amoroso Michael |
Director | Convert | 8,888 |
Showing 1–50 of 504 transactions